Neodynamics
0,075 SEK +6,28 %HC Andersen Capital modtager betaling fra Neodynamics for en Digital IR/Corporate Visibility abonnementsaftale. Læs mere her.
6 investorer følger denne virksomhed
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Omsætning
140 t
EBIT %
-52.307,14 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
NEOD
Daglig lav / høj pris
0,07 / 0,075
SEK
Markedsværdi
52,07 mio. SEK
Aktieomsætning
18,05 t SEK
Volumen
247 t
Analyst

Claus Thestrup
CEO, Sweden
Seneste videoer
Finanskalender
Delårsrapport
17.11.2023
Årsrapport
16.02.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gryningskust Holding AB | 14,0 % | 14,0 % |
Huasheng Fang | 11,3 % | 11,3 % |
Premium
Not activated
This content is for our Premium customers only.
Forum opdateringer
Viser Alle indholdstyper